Before you use Omvoh, review these questions with your doctor: Are you being treated for an infection? Do you have an infection that does not go away or keeps coming back?

Omvoh dosing begins with IV infusions during induction and transitions to self-injections for maintenance 1; Patients can take Omvoh with prefilled pens or prefilled syringes for …

Jan 15, 2025 · Omvoh works to reduce inflammation within the gastrointestinal tract by targeting a specific protein, interleukin-23p19 (IL-23p19), which is a key contributor to intestinal …

OMVOH® mirikizumab 是由礼来公司研发的一款 IL-23抑制剂 。 药物于2023年10月获得FDA批准上市，用于治疗成人溃疡性结肠炎UC。 目前，全球已有多款 IL-23 抑制剂上市，主要适应症 …

Oct 26, 2023 · Omvoh is used to treat moderately to severely active ulcerative colitis or Crohn's disease in adults. It can be self-administered by injection under the skin (subcutaneously) …

Omvoh is a prescription medication indicated for the treatment of adults with moderately to severely active ulcerative colitis.

Sep 3, 2024 · Omvoh (mirikizumab-mrkz) 是一种白细胞介素 23 拮抗剂，可用于治疗中度至重度活动性溃疡性结肠炎的成年人，通过静脉注射（静脉内）或皮下注射给药。 溃疡性结肠炎 (UC) …

Jan 16, 2025 · Omvoh是一种白细胞介素-23拮抗剂，用于治疗成人中度至重度活动期溃疡性结肠炎。

Mirikizumab, sold under the brand name Omvoh, is a monoclonal antibody used for the treatment of ulcerative colitis. [5] It is designed to attach to interleukin-23 (IL-23) and block its activity. [5]

Jan 22, 2025 · OMVOH for intravenous infusion for ulcerative colitis and Crohn's disease. OMVOH (mirikizumab-mrkz) injection is a sterile, preservative-free, clear to opalescent, …